Prednisolone

Prednisolone is a synthetic glucocorticoid, a steroid of the pregnane family closely related to the body's own stress hormone cortisol; it is prized for its potent anti-inflammatory and immunosuppressive actions ^[1]. Chemically it differs only slightly from prednisone, and the two are closely linked in use.

The drug was developed in the mid-1950s as part of the effort to produce more active corticosteroids than natural cortisone. An important relationship is that prednisone itself is a prodrug: it is inactive until the liver converts it into prednisolone, which is the compound that actually acts on tissues, so in practice the two are largely interchangeable ^[2]. Prednisolone appears on the World Health Organization's List of Essential Medicines and is available generically worldwide.

Prednisolone is used very broadly. It treats inflammatory and autoimmune diseases such as rheumatoid arthritis, lupus and inflammatory bowel disease, and it forms part of standard therapy for conditions like autoimmune hepatitis, typically combined with an immunosuppressant ^[4]. It is also used in asthma and allergic reactions, in eye inflammation as ophthalmic drops, in nephrotic syndrome, and as replacement therapy in adrenal insufficiency, among many other roles ^[1]. Its versatility makes it one of the more commonly prescribed medicines.

It is a prescription medicine supplied as tablets, oral solutions and orally disintegrating tablets, as well as injectable and ophthalmic preparations. Short-term effects can include increased appetite, difficulty sleeping and mood changes, while prolonged use carries more serious risks such as bone loss and steroid-induced osteoporosis ^[3], raised blood sugar, greater susceptibility to infection, skin thinning and suppression of the body's own steroid production; for this reason long courses are tapered rather than stopped abruptly ^[1][3].

Prednisolone is prescription only. Short courses are usually well tolerated apart from appetite, mood, sleep, and blood sugar changes. Longer or higher-dose use brings the familiar steroid burden; weight gain and a Cushingoid appearance, thinning bones, muscle weakness, high blood sugar, raised blood pressure, cataracts and glaucoma, thin fragile skin, and greater vulnerability to infection. It suppresses the body's own cortisol production, so after more than a couple of weeks it must be tapered rather than stopped abruptly to avoid an adrenal crisis. It raises ulcer and bleeding risk when combined with NSAIDs, can weaken the response to vaccines, and interacts with drugs cleared by CYP3A4.

Prednisolone is metabolized by CYP3A4, so the enzyme interactions run in both directions. Rifampin, carbamazepine, phenytoin, phenobarbital and St John's wort induce its clearance and can blunt the corticosteroid effect enough to allow a disease flare or, in adrenal replacement, an adrenal crisis. Strong inhibitors including ketoconazole, itraconazole, clarithromycin, ritonavir and cobicistat do the opposite and raise exposure; ritonavir combined with corticosteroids has produced iatrogenic Cushing syndrome.

The pharmacodynamic interactions do more day to day harm. With NSAIDs, the risk of gastrointestinal ulceration and bleeding rises well above either drug alone. With loop or thiazide diuretics and with amphotericin B, potassium loss is additive, which in turn sensitizes the heart to digoxin. Corticosteroids raise blood glucose and work against insulin and oral hypoglycemics, and they move the INR unpredictably in people on warfarin.

Live vaccines given during meaningful immunosuppression can cause disseminated infection, and the response to inactivated vaccines is reduced.

Checking a whole stack? Run it through interactions + stacks.

Prednisolone is a synthetic glucocorticoid that emerged in the mid-1950s as part of the intensive effort to improve upon cortisone and hydrocortisone, the natural adrenal steroids whose anti-inflammatory power had been dramatically demonstrated in rheumatoid arthritis at the end of the 1940s. Chemists introduced a double bond into the steroid ring of hydrocortisone to create prednisolone and its prodrug prednisone, yielding compounds with substantially greater anti-inflammatory potency and relatively less salt-retaining mineralocorticoid activity.

Prednisolone quickly became a workhorse across allergy, asthma, rheumatology, and a wide range of autoimmune and inflammatory diseases, and it is the active form into which the liver converts prednisone. Available in oral, injectable, and ophthalmic formulations, it has been marketed under many names including Prelone, Orapred, and Millipred. Its long clinical history and low cost have secured its place on the World Health Organization's List of Essential Medicines as a fundamental anti-inflammatory and immunosuppressive medicine.

Prednisolone is one of the most trusted and broadly useful anti-inflammatory drugs in medicine, a fast-acting and inexpensive glucocorticoid that can bring dramatic relief across an enormous range of conditions, from asthma flares and severe allergies to rheumatoid arthritis and other autoimmune diseases. Its reliability, low cost, and availability in oral, injectable, and eye-drop forms have made it a genuine essential medicine used worldwide.

Because it acts by switching many genes on and off, its benefits are powerful and wide-ranging; that same breadth, however, is why prolonged or high-dose use carries well-recognized costs, including loss of bone density, elevated blood sugar, and susceptibility to infection. Modern practice reflects this balance, favoring the lowest effective dose and careful tapering, as seen in contemporary rheumatology regimens where a short course is used and then withdrawn. Handled with appropriate respect, prednisolone remains an indispensable and highly effective therapy.